Best Long Term Companies To Watch In Right Now

LONDON -- I believe that shares in�Reckitt Benckiser� (LSE: RB  ) (NASDAQOTH: RBGLY  ) are vastly overpriced and are overdue for a weighty correction. The stock has risen 19% since the turn of the year, and currently trades at a 35% premium to Canaccord Genuity's 3,425 pence target price.

The firm is a giant in the household cleaning product and non-prescription health-care space and whose global brands include�Dettol,�Clearasil, Nurofen, and�Durex, among others. But in my opinion, its loss of exclusivity on its�Suboxone drug --�which is used to combat narcotics addiction -- could harm revenues moving forward and sour investor appetite for the company.

Rivals gear up for assault
The U.S. Food and Drug Administration (FDA) halted Reckitt Benckiser's patent on the anti-addiction product, a move that will herald the entry of cheaper, generic rivals to the�Suboxone�brand and harm sales over the medium to long term.�Suboxone�tablet sales in the U.S. represented around 5% of the firm's total revenues last year, while film made up closer to 10% of group turnover.

Top 10 Cheapest Companies To Watch In Right Now: Digital Cinema Destinations Corp (DCIN)

Digital Cinema Destinations Corp., incorporated on July 29, 2010, operates eight theatres and 73 screens located in Westfield, New Jersey (Rialto), Cranford, New Jersey (Cranford), Bloomfield, Connecticut (the Bloomfield 8) and five theatres located in central Pennsylvania (Cinema Centers). During the fiscal year ended June 30, 2012 (fiscal 2012), the Company operates eight theatres, two in New Jersey, with a total of 11 screens, one in Connecticut, with a total of 8 screens and five in central Pennsylvania, with a total of 54 screens. In March 2014, the Company announced that it has completed the acquisition of a seven screen theater in Churchville, MD from Flagship Cinemas.

The Rialto is a six-screen theatre located in downtown Westfield, New Jersey, which has a population of approximately 30,000 people. The Bloomfield 8 is an eight-screen theatre located at the Wintonbury Mall in the town of Bloomfield, Connecticut, which is a New England town of over 20,000 people that is home to many sites that are on the National Register of Historic Places and is approximately 5.5 miles from downtown Hartford, Connecticut. Cinema Centers consists of a chain of five theatres with 54 screens located throughout central Pennsylvania. All of the Cinema Centers theatres are in free zones. The 11-screen Cinema Center of Bloomsburg theatre is located in Bloomsburg, Pennsylvania. Bloomsburg, a college town of approximately 13,000 people, is located midway between Wilkes Barre and Williamsport, Pennsylvania. The 12-screen Cinema Center of Camp Hill theatre is located in Camp Hill, Pennsylvania, just outside of Harrisburg, Pennsylvania. Harrisburg is the state capital of Pennsylvania with a population of approximately 50,000 people.

The 10-screen Cinema Center at Fairgrounds Square Mall is located in Reading, Pennsylvania. The Company�� Cinema Centers, had one digital projector, RealD 3D enabled. The 12-screen Cinema Center at Selinsgrove is located in Selinsgove, Pennsylvania. Selinsgrove is ! a historic town located on the Susquehanna River with a population of approximately 27,000 people located within five miles of the theatre. The nine-screen Cinema Center of Williamsport is located in Williamsport, Pennsylvania.

The Company competes with Regal Entertainment Group, AMC Entertainment Inc., Clearview and Cinemark USA, Inc.

Advisors' Opinion:

• [By Erin McCarthy]

  Carmike Cinemas Inc.(CKEC), the nation’s fourth-largest movie theater chain, said Thursday it is acquiring Digital Cinema Destinations Corp.(DCIN), a smaller rival that does business as Digiplex.

Best Long Term Companies To Watch In Right Now: Regional Management Corp (RM)

Regional Management Corp. (Regional), incorporated on March 25, 1987, is a diversified specialty consumer finance company providing a range of loan products primarily to customers with limited access to consumer credit from banks, thrifts, credit card companies and other traditional lenders. The Company has a branch network throughout the Southeast and Southwestern United States. Each of its loan products is secured, structured on a fixed rate, fixed term basis with fully amortizing equal monthly installment payments and is repayable at any time without penalty. Regional�� loans are sourced through its multiple channel platform, including in its branches, through direct mail campaigns, independent and franchise automobile dealerships, online credit application networks, furniture and appliance retailers and its consumer Website. On January 20, 2012, it purchased 23 branches in Alabama.

The Company is offering small installment loans, large installment loans, automobile purchase loans, furniture and appliance purchase loans, related credit insurance, and ancillary products and services. As of December 31, 2011, the Company operated offices in 170 locations in the states of Alabama (14 offices), North Carolina (24 offices), Oklahoma (one office), South Carolina (69 offices), Tennessee (18 offices), and Texas (44 offices) under the brand names Regional Finance, RMC Financial Services, Anchor Finance, and Sun Finance. The Company opened 36 offices during the years ended December 31, 2011.

Small Installment Loans

The Company offers small installment loans ranging from $300 to $2,500, with terms of up to 36 months, which are secured by non-essential household goods. The Company also source small installment loans through its live check mailing campaigns to pre-screened individuals. In 2011, the average originated net loan size and term for its small installment loans were $1,022 and 15 months, respectively. Its small installment loans include loans originated throug! h its live check campaigns, which had an average originated net loan size and term of $1,216 and 16 months for 2011. The weighted average yield it earned on its portfolio of small installment loans was 49.3% in 2011. As of December 31, 2011, it had approximately 137,000 small installment loans outstanding representing $130.3 million in finance receivables.

Large Installment Loans

The Company offers large installment loans through its branches ranging from $2,500 to $20,000, with terms of between 18 and 60 months, which are secured by a vehicle in addition to non-essential household goods. Its installment loans are payable in fixed rate, fully amortizing equal monthly installments with terms of 18 to 60 months, and are repayable at any time without penalty. The Company requires its large installment loans to be secured by a vehicle, which may be an automobile, motorcycle, boat or all-terrain vehicle, as well as certain non-essential household goods. In 2011, its average originated net loan size and term for large installment loans were $3,065 and 27 months, respectively. The weighted average yield it earned on its portfolio of large installment loans was 27.6% for 2011. As of December 31, 2011, it had approximately 12,000 large installment loans outstanding representing $36.9 million in finance receivables.

Automobile Purchase Loans

The Company offers automobile purchase loans of up to $30,000, generally with terms of between 36 and 72 months, which are secured by the purchased vehicle. Its automobile purchase loans are offered through a network of dealers in its geographic footprint, including over 2,000 independent and approximately 740 franchise automobile dealerships as of December 31, 2011. Its automobile purchase loans include both direct loans, which are sourced through a dealership and closed at one of its branches, and indirect loans, which are originated and closed at a dealership in its network without the need for the customer to visit o! ne of its! branches. In 2011, it introduced AutoCredit Source branches in the Dallas-Ft. Worth, Texas and Charlotte, North Carolina metropolitan areas, which focus solely on originating, underwriting and servicing indirect automobile purchase loans. As of December 31, 2011, it had approximately 15,000 automobile purchase loans outstanding representing $128.7 million in finance receivables. The Company opened two additional AutoCredit Source branches in Texas in January 2012.

Furniture and Appliance Purchase Loans

The Company offers indirect furniture and appliance purchase loans of up to $7,500, with terms of between six and 48 months, which are secured by the purchased furniture or appliance. Its furniture and appliance purchase loans are indirect loans made through a retailer at the point of sale without the need for the customer to visit one of its branches, similar to its indirect automobile purchase loans. The Company partner with furniture and appliance retailers who offer its furniture and appliance purchase loans directly to their customers. As of December 31, 2011, it provided furniture and appliance purchase loans to customers at approximately 250 furniture and appliance retail locations, including 79 franchise store locations of the furniture retailer in the United States.

Insurance Products

The Company offers its customers optional payment protection insurance relating to many of its loan products. The insurance products it offers customers are voluntary and not a condition of the loan. Its insurance products, including the types of products offered and the terms and conditions thereof, vary from state to state in compliance with applicable laws and regulations. The Company markets and sells insurance policies as an agent for an unaffiliated third-party insurance company. The policies are then ceded to its wholly owned reinsurance subsidiary, RMC Reinsurance, Ltd., which then bears the full risk of the policy. For the sale of insurance policies, th! e Company! , as agent, writes policies within the limitations established by its agency contracts with the unaffiliated third-party insurance company.

Credit Life Insurance, Credit Accident and Health Insurance and Involuntary Unemployment Insurance

The Company markets and sells optional credit life insurance, credit accident and health insurance and involuntary unemployment insurance in connection with its loans in selected markets. Credit life insurance provides for the payment in full of the borrower�� credit obligation to the lender in the event of the borrower�� death. Credit accident and health insurance, which is only offered in conjunction with credit life insurance, provides for the repayment of loan installments to the lender that come due during an insured�� period of income interruption resulting from disability from illness or injury. Involuntary unemployment insurance provides for repayment of loan installments in the event the borrower is no longer employed as the result of a layoff or reduction in workforce. All customers purchasing these types of insurance from the Company sign a statement on the loan contract affirming that they understand that their purchase of insurance is not a condition of its granting the loan.

Collateral Protection Collision Insurance

The Company before originate an automobile purchase loan or large installment loan, it require the borrower to provide proof of acceptable liability and collision insurance on the vehicle securing the loan. While the Company do not offer automobile insurance to its customers, it will obtain collateral protection collision insurance (CPI) on behalf of customers who permit their other insurance coverage to lapse. If it obtains CPI for a vehicle, the customer has the opportunity to provide proof of insurance to cancel the CPI and receive a refund of all unearned premiums.

Property Insurance

The Company also requires that its customers provide proof of acceptable ! insurance! for any personal property securing a loan. Customers can provide proof of such insurance purchased from a third party (such as homeowners or renters insurance) or can purchase the property insurance that it offers.

The Company competes with World Acceptance Corp. and Security Finance Corporation.

Advisors' Opinion:

• [By Peter Graham]

  Small cap installment loan and consumer finance�stock World Acceptance Corp (NASDAQ: WRLD), a potential peer of small cap Regional Management Corp (NYSE: RM) and�mid cap�Springleaf Holdings Inc (NYSE: LEAF), has elevated short interest of 38.72% according to Highshortinterest.com. However, World Acceptance Corp got on the radar of the shorts when the company disclosed that its being investigated by the Consumer Financial Protection Bureau�for its lending practices. ��

Best Long Term Companies To Watch In Right Now: Oncothyreon Inc .(ONTY)

Oncothyreon Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic products for the treatment of cancer. Its primary product candidate, Stimuvax is in two phase III clinical trials for the treatment of non-small cell lung cancer. The company is also developing PX-866, a small molecule that is in phase II trials for various cancer indications. In addition, it engages in the preclinical development of ONT-10, a cancer vaccine; and ONT-701, a pan-inhibitor of the B-cell lymphoma-2 family of anti-apoptotic proteins. The company operates primarily in the United States and Canada. Oncothyreon Inc. was founded in 1985 and is headquartered in Seattle, Washington.

Advisors' Opinion:

• [By EP Vantage]

  Although the subgroup on which this decision is based was large, many will still consider this a risky basis for further study. Some investors thought it was a risk worth taking: shares in Oncothyreon (ONTY), which licensed the drug to Merck and saw its valuation more than halve on news of the Start failure, were trading 22% higher this morning at $2.19; Merck KGaA stock was little changed. But, in the meantime, tecemotide will struggle to shake off the stain of past failure.

• [By WWW.DAILYFINANCE.COM]

  D Dipasupil/FilmMagicJustin Bieber's Someday perfume. Plenty of stocks go up and down in any given week. The gainers inspire us to keep investing. The decliners keep greed in check while reminding us about the risks of the equity markets. Let's go over some of last week's best and worst performers. China Finance Online (JRJC) -- Up 131 percent last week The market's biggest winner last week was China Finance Online, more than doubling after introducing a new trading platform. The Beijing-based financial website operator announced that the new offering was the country's first integrated, Web-based securities trading service platform. At least one noted worrywart disputed the claim. Citron Research -- a popular publisher of bearish reports on stocks -- tweeted that sloppy reporting and a misleading headline were making it seem as if no other online trading platform existed in the world's most populous nation. The bulls won out. Shares of China Finance Online closed sharply higher in each of last week's five trading days. TrueCar (TRUE) -- Up 33 percent last week Closer to home, another online platform moved nicely higher after striking a deal with Chrysler and auto insurer GEICO (BRK-A). TrueCar operates a negotiation-free car buying and selling platform. It launched a platform that could shake up the insurance industry, where roughly 3 million cars are totaled each year. Insurers have typically just written a settlement check and provided a rental car voucher to cover the incident, but TrueCar's new plan would work with launch partners GEICO and Chrysler -- and other members of its insurance affinity partners in the future -- to work with the insured to directly replace the vehicle. TrueCar went public at $9 just three months ago. The stock has been revving higher, going on to more than double in its brief time on the market. American Eagle Outfitters (AEO) -- Up 26 percent last week Shares of American Eagle Outfitters moved higher after it posted b

Best Long Term Companies To Watch In Right Now: Nektar Therapeutics(NKTR)

Nektar Therapeutics, a clinical-stage biopharmaceutical company, engages in developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. The company?s product pipeline consists of drug candidates across various therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and immunology. Its research and development activities involve small molecule drugs, peptides, and other potential biologic drug candidates. The company?s proprietary drug candidates in clinical development comprise NKTR-118, a peripheral opioid antagonist, which has completed Phase II clinical trail for the treatment of opioid-induced constipation; BAY41-6551 that has completed Phase II clinical trail to treat gram-negative pneumonias; NKTR-102, a topoisomerase I inhibitor-polymer conjugate, which is in Phase II clinical trail for multiple cancer indications, including breast, ovarian, and colorectal; and NKTR-105 that is in Phase I clinica l trail to treat solid tumors. Its preclinical products consists of NKTR-119 (Opioid/NKTR-118 combinations) for the treatment of pain; NKTR-181 (abuse deterrent, tamper-resistant opioid) to treat pain; NKTR-194 (non-scheduled opioid) for the treatment of mild to moderate pain; NKTR-171 (tricyclic antidepressant) to treat neuropathic pain; and NKTR-140 (protease inhibitor candidate) to treat HIV. The company has collaboration with Bayer Healthcare LLC to develop BAY41-6551 (NKTR-061, Amikacin Inhale), which is an inhaled solution of amikacin, an aminoglycoside antibiotic; and a license agreement with AstraZeneca AB for the development and commercialization of Oral NKTR-118 and NKTR-119. In addition, Nektar Therapeutics has various license, manufacturing, and supply agreements for its technology with biotechnology and pharmaceutical companies, such as Affymax, Amgen, Baxter, Roche, Merck, Pfizer, and UCB Pharma. The company was founded in 1990 and is headquartered in San Franc isco, California.

Advisors' Opinion:

• [By John McCamant]

  Nektar Therapeutics (NKTR) is expected to get FDA approval this year for its lead drug naloxegol, a once-a-day pill for opioid-induced constipation (OIC). The drug is licensed to AstraZeneca. NKTR will receive up to $245 million in milestone payments, plus royalties.

• [By Jay Silverman]

  Steve Halpern: Another stock you follow closely is Nektar (NKTR). What do you see happening there?

  Jay Silverman: Yes, Nektar is another platform company at the MTSL and they are about to release data on one of their compounds that is a pain reliever-unlike the very severe side effects of OxyContin, the opioid pain relievers that are out there, which have caused severe health and addictive concerns, leading to very, very troublesome side effects and death in some cases.

• [By Luke Jacobi]

  Nektar Therapeutics (NASDAQ: NKTR) were down 23.90 percent to $10.54 after the company reported that the results from Phase 2 trial of NKTR-181 missed primary efficacy endpoint.

• [By Rich Bieglmeier]

  Wednesday, June 11, 2014 could be a happy or sad day for event traders who follow the Food and Drug Association's (FDA) calendar. Two biotechs with considerable potential are slated to hear from the regulatory body regarding their applications for approval.

  Nektar Therapeutics (NASDAQ:NKTR) Orexigen Therapeutics, Inc. (NASDAQ:OREX)

  The duo hopes to see �thumbs up from the FDA in a little more than a week. If all things go well, it could be party time for shareholders too.